CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers

被引:38
|
作者
Jin, Chuan [1 ]
Ma, Jing [1 ]
Ramachandran, Mohanraj [1 ]
Yu, Di [1 ]
Essand, Magnus [1 ]
机构
[1] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
NEUTROPHIL-ACTIVATING PROTEIN; CHIMERIC ANTIGEN RECEPTOR; IMMUNOTHERAPY; INFILTRATION; LYMPHOCYTES; EFFICACY; SURVIVAL; THERAPY;
D O I
10.1038/s41551-022-00875-5
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Chimeric antigen receptor T cells (CAR T cells) are effective against haematologic malignancies. However, in solid tumours, their potency is hampered by local immunosuppression and by the heterogeneous expression of the antigen that the CAR targets. Here we show that CAR T cells expressing a pluripotent pro-inflammatory neutrophil-activating protein (NAP) from Helicobacter pylori trigger endogenous bystander T-cell responses against solid cancers. In mice with subcutaneous murine pancreatic ductal adenocarcinomas, neuroblastomas or colon carcinomas, CAR(NAP) T cells led to slower tumour growth and higher survival rates than conventional mouse CAR T cells, regardless of target antigen, tumour type and host haplotype. In tumours with heterogeneous antigen expression, NAP secretion induced the formation of an immunologically 'hot' microenvironment that supported dendritic cell maturation and bystander responses, as indicated by epitope spreading and infiltration of cytotoxic CD8(+) T cells targeting tumour-associated antigens other than the CAR-targeted antigen. CAR T cells armed with NAP neither increased off-tumour toxicity nor hampered the efficacy of CAR T cells, and hence may have advantageous translational potential. T cells expressing a pluripotent pro-inflammatory neutrophil-activating protein from Helicobacter pylori trigger endogenous bystander T-cell responses against solid cancers.
引用
收藏
页码:830 / 841
页数:25
相关论文
共 50 条
  • [21] Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand-Expressing Solid Tumors
    Bajgain, Pradip
    Chavez, Alejandro G. Torres
    Balasubramanian, Kishore
    Fleckenstein, Lindsey
    Lulla, Premal
    Heslop, Helen E.
    Vera, Juan
    Leen, Ann M.
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (11) : 1370 - 1385
  • [22] A novel approach to limit off-tumor toxicity of CAR-T cells targeting solid cancers
    Bartlett, Alex
    Mcwhorter, Matthew
    Collier, Camille
    Jenkins, Chelsea
    Eil, Robert
    CANCER RESEARCH, 2024, 84 (07)
  • [23] Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues
    Feng, Zijie
    He, Xin
    Zhang, Xuyao
    Wu, Yuan
    Xing, Bowen
    Knowles, Alison
    Shan, Qiaonan
    Miller, Samuel
    Hojnacki, Taylor
    Ma, Jian
    Katona, Bryson W.
    Gade, Terence P. F.
    Schrader, Joerg
    Metz, David C.
    June, Carl H.
    Hua, Xianxin
    NATURE CANCER, 2022, 3 (05) : 581 - +
  • [24] Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues
    Zijie Feng
    Xin He
    Xuyao Zhang
    Yuan Wu
    Bowen Xing
    Alison Knowles
    Qiaonan Shan
    Samuel Miller
    Taylor Hojnacki
    Jian Ma
    Bryson W. Katona
    Terence P. F. Gade
    Don L. Siegel
    Jörg Schrader
    David C. Metz
    Carl H. June
    Xianxin Hua
    Nature Cancer, 2022, 3 : 581 - 594
  • [25] BANANA LECTIN EXPRESSING CAR T CELLS ENHANCE ANTI-TUMOR ACTIVITY AGAINST HETEROGENOUS SOLID TUMORS
    Mckenna, K.
    Ozcan, A.
    Markovitz, D.
    Brenner, M.
    HUMAN GENE THERAPY, 2023, 34 (21-22) : A21 - A21
  • [26] IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
    Zhao, Yang
    Chen, Jiangqing
    Andreatta, Massimo
    Feng, Bing
    Xie, Yu-Qing
    Wenes, Mathias
    Wang, Yi
    Gao, Min
    Hu, Xiaomeng
    Romero, Pedro
    Carmona, Santiago
    Sun, Jie
    Guo, Yugang
    Tang, Li
    NATURE BIOTECHNOLOGY, 2024, 42 (11) : 1693 - 1704
  • [27] ARMORED GLYPICAN 3-CAR T CELLS CO-EXPRESSING INTERLEUKIN-15 FOR PATIENTS WITH SOLID TUMORS
    Steffin, David
    Ghatwai, Nisha
    Zhang, Chunchao
    Rathi, Purva
    Courtney, Amy
    Ramos, Carlos
    Lulla, Premal
    Armaghanny, Tannaz
    Grilley, Bambi
    Metelitsa, Leonid
    Heslop, Helen
    Brenner, Malcolm
    Sumazin, Pavel
    Heczey, Andras
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S90 - S90
  • [28] Oncolytic virus expressing RANTES and IL-15 enhances function of CAR-modified T cells in solid tumors
    Nishio, Nobuhiro
    Dotti, Gianpietro
    ONCOIMMUNOLOGY, 2015, 4 (02): : 1 - 3
  • [29] Factor VIII-specific CAR regulatory T cells modulate murine anti-factor VIII immune responses
    Fu, Richard
    Lyle, Meghan J.
    Wang, Xuefeng
    Miao, Carol H.
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [30] Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells
    Dobrzynski, E
    Fitzgerald, JC
    Cao, O
    Mingozzi, F
    Wang, LX
    Herzog, RW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (12) : 4592 - 4597